Immunotherapy for Blood Disorders

Immunotherapy is a sort of treatment that harnesses the immune system of the patient to combat illnesses, particularly blood problems. It entails the use of medications or other substances to enhance the immune system's capacity to spot and eliminate cancer cells or other aberrant cells.

Immunotherapy has showed promise in the treatment of several malignancies, including leukaemia and lymphoma, in the area of blood disorders. Chimeric antigen receptor (CAR) T-cell treatment is one sort of immunotherapy that has been effective in treating certain blood malignancies. This entails directing a patient's own immune cells, known as T-cells, to seek out and eradicate cancer cells.
 

  • Immune Checkpoint Inhibitors in Hematologic Malignancies
  • Monoclonal Antibodies for Hematologic Malignancies
  • CAR T-Cell Therapy for Multiple Myeloma
  • Novel Approaches to Immunotherapy for Bleeding Disorders

Related Conference of Immunotherapy for Blood Disorders

May 28-29, 2026

5th European Congress on Hematology

Madrid, Spain
August 10-11, 2026

24th World Hematology Congress

Berlin, Germany

Immunotherapy for Blood Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in